Library Subscription: Guest
International Journal of Medicinal Mushrooms

Published 12 issues per year

ISSN Print: 1521-9437

ISSN Online: 1940-4344

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.2 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 1.4 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00066 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.34 SJR: 0.274 SNIP: 0.41 CiteScore™:: 2.8 H-Index: 37

Indexed in

Professor Solomon P. Wasser and Medicinal Mushroom Science, with Special Attention to the Problems of Mycotherapy in Oncology

Volume 24, Issue 1, 2022, pp. 13-26
DOI: 10.1615/IntJMedMushrooms.2021041831
Get accessDownload

ABSTRACT

This article is dedicated to the 75th anniversary of Solomon P. Wasser and discusses the challenges within the research direction he founded with Professors T. Mizuno, S.T. Chang, and other colleagues, known as medicinal mushroom science. This research organically grows out of taxonomic studies, since understanding of the classification system leads to greater ability to make forecasts and predictions in the practical field as well as to increase knowledge of close relationships between organisms, allowing greater eeconomic organization within the search and screening for new practically significant organisms. Through the efforts of Professors Wasser, Mizuno, and Chang, the International Journal of Medicinal Mushrooms (IJMM) was created, combining the efforts of physicians using mushroom raw materials as an auxiliary tool and specialists in fungal biotechnology. In this work, the basic prerequisites for cancer mycotherapy are described, based on data on the mechanism of action of fungal metabolites on cancer targets. A large section of this report is devoted to a review of evidence-based medicine tools and an overview of their use among teams of Chinese researchers. It has been shown that the main recipients of mycotherapy, as well as other types of immunotherapies, are patients with stage 3 cancer who have undergone surgery to remove the primary tumor node and are undergoing chemotherapy; for these patients, their immune status must be increased, and the immune system requires a periodic rebooting. In this respect, Dectin stimulation using fungal glucans is comparable to cytokine therapy and can be characterized as an "endogenous cytokine therapy." The results of the combined treatment at this stage are to be quantified using evidence-based medicine tools, for which we recommend including the consumption of mushroom extracts in the patient questionnaire. This article also discusses challenges in the pharmacokinetics of β-glucans and triterpenoids.

REFERENCES
  1. Bon M. Cle monographique du genre Agaricus L.: Fr. (Sousgenre Agaricus). Doc Mycol. 1985;15(60):1-37.

  2. Bon M. Studies in Lepiota II. Doc Mycol. 1993;22(88):29.

  3. Navrotskaya IL, Kondratyuk SYa, Wasser SP, Nevo E. Lichens and lichenicolous fungi new for Israel and other countries. Israel J Plant Sci. 1996;44(2-3):181-93.

  4. Zmitrovich IV, Malysheva VF, Spirin WA. A new Pachykytospora species (Basidiomycota, Polyporales) from Zhuguli, European Russia. Ukr Bot J. 2007;64(1):42-6.

  5. Bukhtiyarova LN, Pomazkina GV. Bacillariophyta of Lake Baikal. Vol. 1. Genera Baikalia, Slavia, Navigeia, Placogeia, Grachevia, Goldfishia, Nadiya, Cymbelgeia. Lvov, Ukraine: Kholodny Institute of Botany; 2013.

  6. Crous PW, Kolling DA, Maggs-Cowan G, Yilmaz N, Thangavel R, Wingfield MJ, Noordeloos ME, Dima B, Brandrud TE, Jansen GM, Morozova OV, Vila J, Shivas RG, Tan YP, Bishop-Hurley S, Lacey E, Marney TS, Larsson E, LeFloch G, Lombard L, Nodet P, Hubka V, Alvarado P, Berraf-Tebbal A, Reyes JD, Delgado G, Eichmeier A, Jordal JB, Kachalkin AV, Kubatova A, Macia-Vicente JG, Malysheva EF, Papp V, Rajeshkumar KC, Sharma A, Spetik M, Szaboova D, Tomashevskaya MA, Abad JA, Abad ZG, Alexandrova AV, Anand G, Arenas F, Ashtekar N, Balashov S, Banares A, Baroncelli R, Bera I, Biketova AYu, Blomquist CL, Boekhout T, Boertmann D, Bulyonkova TM, Burgess TI, Carnegie AJ, Cobo-Diaz JF, Corriol G, Cunnington JH, daCruz MO, Damm U, Davoodian N, MdeASantiago ALC, Dearnaley J, de Freitas LWS, Dhileepan K, Dimitrov R, DiPiazza S, Fatima S, Fuljer F, Galera H, Ghosh A, Giraldo A, Glushakova AM, Gorczak M, Gouliamova DE, Gramaje D, Groenewald M, Gunsch CK, Gutierrez A, Holdom D, Houbraken J, Ismailov AB, Istel L, Iturriaga T, Jeppson M, Jurjevic Z, Kalinina LB, Kapitonov VI, Kautmanova I, Khalid AN, Kiran M, Kiss L, Kovacs A, Kurose D, Kusan I, Lad S, Laessoe T, Lee HB, Luangsa-ard JJ, Lynch M, Mahamedi AE, Malysheva VF, Mateos A, Matocec N, Mesic A, Miller AN, Mongkolsamrit S, Moreno G, Morte A, Mostowfizadeh-Ghalamfarsa R, Naseer A, Navarro-Rodenas A, Nguyen TTT, Noisripoom W, Ntandu JE, Nuytinck J, Ostry V, Pankratov TA, Pawlowska J, Pecenka J, Pham THG, Polhorsky A, Posta A, Raudabaugh DB, Reschke K, Rodriguez A, Romero M, Rooney-Latham S, Roux J, Sandoval-Denis M, Smith MTh, Steinrucken TV, Svetasheva TY, Tkalcec Z, vander Linde EJ, Vegte Mvd, Vauras J, Verbeken A, Visagie CM, Vitelli JS, Volobuev SV, Weill A, Wrzosek M, Zmitrovich IV, Zvyagina EA, Groenewald JZ. Fungal planet description sheets: 1182-1283. Persoonia. 2021;46:1236.

  7. Starobogatov YI. Natural system and artificial systems (Goals and principles of work of the taxonomist). Vestnik Zoologii. 1989;6:3-7.

  8. Zmitrovich IV, Psurtseva NV, Belova NV. Evolutionary-taxonomic aspects of the search and study of lignin-destroying fungi - active producers of oxidative enzymes. Mikol Fitopatol. 2007;41(1):57-78.

  9. Psurtseva NV, Belova NV, Shakhova NV, Zmitrovich IV. Oxidative potential of macromycetes ex situ: Recent achievements in screening for novel laccase producers [Abstract]. In: XV Congress of European Mycologists. Saint Petersburg, Russia, September 16-21, 2007. St. Petersburg, Russia: European Mycological Association; 2007. p. 201.

  10. Tura D, Zmitrovich IV, Wasser SP. Wood-inhabiting fungi: Applied aspects. In: Fungi: Applications and management strategies. New York, NY: CRC Press; 2016. p. 245-92.

  11. Kusakin OG, Drozdov AL. The phylem of the organic beings. Part I. Prolegomena to phyleme construction. St. Petersburg, Russia: Nauka; 1994.

  12. Wasser SP, Soldatova IM. Higher Basidiomycetes of the steppe zone of Ukraine. Kiev, Ukraine: Naukova Dumka Press; 1977.

  13. Wasser SP. Fungal flora of Ukraine: Agaricaceae. Kiev, Ukraine: Naukova Dumka Press; 1980.

  14. Wasser SP. The Agaricales fungi of the USSR. Kiev, Ukraine: Naukova Dumka Press; 1985.

  15. Wasser SP. The fungal flora of Ukraine: Amanitales. Kiev, Ukraine: Naukova Dumka Press; 1992.

  16. Wasser SP, editor. Evolutionary theory and processes: Modern perspectives. Dordrecht, Netherlands: Kluwer Academic Publishers; 1999.

  17. Wasser SP, editor. Evolutionary theory and processes: Modern horizons. Dordrecht, Netherlands: Kluwer Academic Publishers; 2004.

  18. Wasser SP, Frenkel-Morgenstern M, editors. New horizons in evolution. Amsterdam, Netherlands: Academic Press/Elsevier; 2021.

  19. Bisko NA, Bukhalo AS, Wasser SP, Dudka IA, Kulesh MD, Solomko EF, Shevchenko SV. Higher edible Basidiomycetes in surface and submerged culture. Kiev, Ukraine: Naukova Dumka Press; 1983.

  20. Wasser SP. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol. 2002;60:258-74.

  21. Wasser SP. Reishi or lingzhi (Ganoderma lucidum). In: Encyclopedia of dietary supplements. New York, NY: Marcel Dekker; 2005. p. 603-22.

  22. Wasser SP. Shiitake (Lentinus edodes). In: Encyclopedia of dietary supplements. New York, NY: Marcel Dekker; 2005. p. 653-64.

  23. Didukh MY, Wasser SP, Nevo E. Medicinal value of species of the family Agaricaceae Cohn (higher Basidiomycetes): Current stage of knowledge and future perspectives. Int J Med Mushrooms. 2003;5:133-52.

  24. Wasser SP. Medicinal mushroom science: History, current status, future trends, and unsolved problems. Int J Med Mushrooms. 2010;12(1):1-16.

  25. Zhuang C, Wasser SP. Medicinal value of culinary-medicinal maitake mushroom Grifola frondosa (Dicks.: Fr.) S. F. Gray (Aphyllophoromycetidae). Review. Int J Med Mushrooms. 2004;6:287-313.

  26. Petrova RD, Reznick AZ, Wasser SP, Denchev CM, Nevo E, Mahajna J. Fungal metabolites modulating NF-KB activity: An approach to cancer therapy and chemoprevention (Review). Oncol Rep. 2008;19:299-308.

  27. Petrova RD, Mahaja J, Wasser SP, Ruimi N, Denchev C, Sussan S, Nevo E, Reznick AZ. Marasmius oreades substances block NF-KB activity through interference with IKK activation pathway. Mol Biol Rep. 2009;36:737-44.

  28. Zaidman B-Z, Wasser SP, Nevo E, Mahaja J. Androgen receptor-dependent and independent mechanisms mediate Ganoderma lucidum activities in LNCaP prostate cancer cells. Int J Oncol. 2007;31:959-67.

  29. Zaidman B-Z, Wasser SP, Nevo E, Mahajna J. Coprinus comatus and Ganoderma lucidum interfere with androgen receptor function in LNCaP prostate cancer cells. Mol Biol Rep. 2008;35:107-17.

  30. Mahajna J, Dotan N, Zaidman B-Z, Petrova RD, Wasser SP. Pharmacological values of medicinal mushrooms for prostate cancer therapy: The case of Ganoderma lucidum. Nutr Cancer. 2009;61(1):16-26.

  31. Wasser SP, editor. Macromycetes: Medicinal properties and biological characteristics. Kiev, Ukraine: Kholodny Institute of Botany; 2012.

  32. Wasser SP. Medicinal mushroom science: Current perspectives, advances, evidences, and challenges. J Biomed. 2014;37(6):345-56.

  33. Chang ST, Wasser SP. Current and future research trends in agricultural and biomedical applications of medicinal mushrooms and mushroom products (review). Int J Med Mushrooms. 2018;20(11):1034-48.

  34. Park H-G, Shim YY, Choi S-O, Park W-M. New method development for nanoparticle extraction of water-soluble P-(1-3)-D-glucan from edible mushrooms, Sparassis crispa and Phellinus linteus. Agric Food Chem. 2009;57:2147-54.

  35. Alexeeva A. ("Renoir") Medical myths about mushrooms: Chaga. XX2 BEK. [updated 2020 Oct 27; cited 2021 Jan 8]. Available from: https://22century.ru/popular-science-publications/mushroom-medical-myths.

  36. Jin X, Beguerie JR, Sze DM, Chan GCF. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database Syst Rev. 2012;4(4):CD007731.

  37. Money NP. Are mushrooms medicinal? Fungal Biol. 2016;129(4):449-53.

  38. Chmielowski B, Territo M. Manual of clinical oncology. Philadelphia, PA: Lippincott Williams and Wilkins; 2017.

  39. Chu E, DeVita VT. Physicians' cancer chemotherapy drug manual. Amsterdam, Netherlands: Elsevier; 2020.

  40. Zhong L, Yan P, Lam WC, Yao L, Bian Z. Coriolus versicolor and Ganoderma lucidum related natural products as an adjunct therapy for cancers: A systematic review and meta-analysis of randomized controlled trials. Front Pharmacol. 2019;10:703.

  41. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Int Med. 2009;151:264-9.

  42. Higgins JPT, Green S (eds). Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011; cited 2021 Jan 8]. London, UK: Cochrane Collaboration; 2011. Available from http://www.cochrane-handbook.org.

  43. Swaminathan R, Brenner H. Statistical methods for cancer survival analysis. IARC Sci Pub. 2011;162:7-13.

  44. Townson JL, Chambers AF. Dormancy of solitary metastatic cells. Cell Cycle. 2006;5:1744-50.

  45. Higham E, Wittrup KD, Chen J. Activation of tolerogenic dendritic cells in the tumor draining lymph nodes by CD8+ T cells engineered to express CD40 ligand. J Immunol. 2010;184(7):3394-400.

  46. Brenner H. Long-term survival rates of cancer patients achieved by the end of the 20th century: A period analysis. Lancet. 2002;360(9340):1131-5.

  47. Rich R, editor. Clinical immunology: Principles and practice. 3rd ed. St Louis, MO: Mosby; 2008.

  48. Bukowski RM. Cytokine therapy for metastatic renal cell carcinoma. Semin Urol Oncol. 2001;19(2):148-54.

  49. Ilyushin AL, Krasnaya YL, Shabalkin PI. Results of an open comparative study in parallel groups to assess the efficacy and safety of the drug Refnot (Tumor necrosis factor - thymosin-1 alpha recombinant) in the treatment of disseminated triple negative breast cancer. Medicine. 2019;7(3):138-49.

  50. Zmitrovich IV, Vlasenko VA, Perelygin VV, Figurin IS. Prevention and treatment of cancer using so-called medicinal mushrooms raw materials: Criticism, facts, and perspectives. Pharmacy Formulas. 2021;2(4):118-27.

  51. Brown GD, Herre J, Williams DL. Dectin-1 mediates the biological effects of beta-glucans. J Experiment Med. 2003;197(9):1119-24.

  52. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by dectin-1 and toll-like receptor 2. J Exp Med. 2003;97(9):1107-17.

  53. Gross O, Gewies A, Finger K, Schafer M, Sparwasser T, Peschel C, Forster I, Ruland J. Card9 controls a non-TLR signaling pathway for innate anti-fungal immunity. Nature. 2006;442(7103):651-6.

  54. Ikeda Y, Adachi Y, Ishii T, Miura N, Tamura H, Ohno N. Dissociation of toll-like receptor 2-mediated innate immune response to zymosan by organic solvent-treatment without loss of dectin-1 reactivity. Biol Pharmaceut Bull. 2008;31(1):13-8.

  55. Dennehy KM, Brown GD. The role of the P-glucan receptor dectin-1 in control of fungal infection. J Leukoc Biol. 2007;82(2):253-8.

  56. Raker VK, Domogalla MP, Steinbrink K. Tolerogenic dendritic cells for regulatory T cell induction in man. Front Immunol. 2015;6:569.

  57. Jiang J, Slivova V, Valachovicova T, Harvey K, Sliva D. Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3. Int J Oncol. 2004;24:1093-9.

  58. Xia Q, Zhang H, Sun X, Zhao H, Wu L, Zhu D, Yang G, Shao Y, Zhang X, Mao X, Zhang L, She G. A comprehensive review of the structure elucidation and biological activity of triterpenoids from Ganoderma spp. Molecules. 2014;19:17478-535.

  59. Wagner EF, Nebreda AR. Signal integration by JNK and p39 MAPK pathways in cancer development. Nat Rev Cancer. 2009;9:537-49.

  60. Hilger RA, Scheulen ME, Strumberg D. The Ras-Raf-MEK-ERK pathway in the treatment of cancer. Onkologie. 2002;25:511-8.

  61. Zmitrovich IV, Belova NV, Balandaykin ME, Bondartseva MA, Wasser SP. Cancer without pharmacological illusions and a niche for mycotherapy (Review). Int J Med Mushrooms. 2019;21(2):105-19.

  62. Chan GCF, Chan WK, Sze DMY. The effects of P-glucan on human immune and cancer cells. J Hematol Oncol. 2009;2:25.

  63. Hyde KD, Xu J, Rapior S, Jeewon R, Lumyong S, Niego AGT, Abeywickrama PD, Aluthmuhandiram JVS, Brahamanage RS, Brooks S, Chaiyasen A, Chethana KWT, Chomnunti P, Chepkirui C, Chuankid B, de Silva NI, Doilom M, Faulds C, Gentekaki E, Gopalan V, Kakumyan P, Harishchandra D, Hemachandran H, Hongsanan S, Karunarathna A, Karunarathna SC, Khan S, Kumla J, Jayawardena RS, Liu J-K, Liu N, Luangharn T, Macabeo APG, Marasinghe DS, Meeks D, Mortimer PE, Mueller P, Nadir S, Nataraja KN, Nontachaiyapoom S, O'Brien M, Penkhrue W, Phukhamsakda C, Ramanan US, Rathnayaka AR, Sadaba RB, Sandargo B, Samarakoon BC, Tennakoon DS, Siva R, Sriprom W, Suryanarayanan TS, Sujarit K, Suwannarach N, Suwunwong T, Thongbai B, Thongklang N, Wei D, Wijesinghe SN, Winiski J, Yan J, Yasanthika E, Stadler M. The amazing potential of fungi: 50 ways we can exploit fungi industrially. Fungal Divers. 2019;97:1-136.

  64. Furtado NAJC, Pirson L, Edelberg H, Miranda LM, Loira-Pastoriza C, Preat V, Larondelle Y, Andre CM. Pentacyclic triterpene bioavailability: An overview of in vitro and in vivo studies. Molecules. 2017;22:400.

CITED BY
  1. Zmitrovich Ivan V., Perelygin Vladimir V., Zharikov Mikhail, Supergroups of eukaryotes through a biotechnologist’s look. The system of eukaryotes and the need for a taxonomic/biotechnological interface, Pharmacy Formulas, 2022. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain